Home
Bio-Rad Laboratories BIO paid Forbes-Tate $20K for lobbying in Q3 2026 · Medicare, Health Issues and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q3 2026
- Client
- Bio-Rad Laboratories
- Reported
- 26/09/02
Down 75.0% from last quarter
What else happened in Bio-Rad Laboratories around then
Filed or reported within 30 days of the trade day · 08/31~10/30Bio-Rad Laboratories's other lobbying reports
- Bio-Rad Laboratories
LobbyingBio-Rad Laboratories
LobbyingBio-Rad Laboratories
BIO
$80K
$80K
Reported 07/20
for Q2
- Bio-Rad Laboratories
LobbyingBio-Rad Laboratories
LobbyingBio-Rad Laboratories
BIO
$80K
$80K
Reported 04/17
for Q1
- Bio-Rad Laboratories
LobbyingBio-Rad Laboratories
LobbyingBio-Rad Laboratories
BIO
$80K
$80K
Reported 01/18
for Q4 2025
- Bio-Rad Laboratories
LobbyingBio-Rad Laboratories
LobbyingBio-Rad Laboratories
BIO
$80K
$80K
Reported 25/10/19
for Q3 2025
- Bio-Rad Laboratories
LobbyingBio-Rad Laboratories
LobbyingBio-Rad Laboratories
BIO
$80K
$80K
Reported 25/07/18
for Q2 2025